Amerikanische Gesellschaft für Hirudotherapie

Hirudin and decorsins of the North American medicinal leech: gene structure reveals homology to hirudins and hirudin-like factors of Eurasian medicinal leeches

Basic science / molecular biology published in J Parasitol (2019)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Preclinical (animal)Genomik & ProteomikSpeichel-PharmakologieMuller C et al. · The Journal of parasitology, 2019

Abstract

Blood-sucking leeches, some of which are referred to as medicinal leeches, have caught attention not only because of their medical purposes, but also as study organisms to conduct research within fields as diverse as neurobiology, osmoregulation, ecology, and phylogeny. Of particular interest is the question whether hemophagy in leeches is of single origin or evolved independently several times. A key component in the saliva of hematophagous leeches is hirudin, a strong natural inhibitor of thrombin and hence the blood coagulation cascade. Multiple isoforms of hirudin have been described within and among several leech species and genera, often based on sequence data only. The identification of hirudin-like factors (HLFs) illustrated the necessity to underpin such predictions by functional tests. We overexpressed and purified the hirudin of the North American medicinal leech, Macrobdella decora, and proved its thrombin-inhibiting activity. In addition, analysis of the gene structure of both hirudin and some of the decorsins of M. decora clearly indicated conserved exon and intron positions when compared to genes of hirudins and HLFs of Eurasian medicinal leeches. Our data provide evidence for the incorporation of decorsins into the hirudin superfamily and support the concept of a single origin of blood feeding in jawed leeches.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAmino Acid SequenceAnimalsAsiaBlood Coagulation TestsCell Adhesion MoleculesDNA, ComplementaryEuropeExonsGenotyping TechniquesHirudinsIntronsLeeches

Zusammenfassung

Functional characterization of North American medicinal-leech hirudin demonstrating thrombin-inhibition activity. Gene structure of hirudin and decorsins reveals conserved exon-intron positions with Eurasian leeches, supporting single-origin hematophagy.

Warum dies für die Hirudotherapie relevant ist

This study overexpressed and purified hirudin from the North American medicinal leech Macrobdella decora and demonstrated its thrombin-inhibiting activity, while gene-structure analysis of hirudin and decorsins showed conserved exon/intron positions compared to hirudins and hirudin-like factors of Eurasian medicinal leeches. The authors argue this supports inclusion of decorsins in the hirudin superfamily and a single origin of blood feeding in jawed leeches. This is relevant to ASH's domain as it characterizes a key bioactive component of the leech secretome—a potent thrombin inhibitor—across leech lineages. The work is molecular/biochemical in scope, not a clinical trial, and provides no in-vivo efficacy, safety, or clinical hirudotherapy data.

Zitation

Hirudin and decorsins of the North American medicinal leech: gene structure reveals homology to hirudins and hirudin-like factors of Eurasian medicinal leeches.

Muller C et al. · The Journal of parasitology, 2019

Verwandter klinischer Kontext

Zur ASH-Bibliothek hinzugefügt: May 27, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.